Zepbound maker Eli Lilly hits $1T market cap — becoming first drug company to reach milestone
A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
